AIRLINK 71.69 Decreased By ▼ -2.41 (-3.25%)
BOP 5.00 No Change ▼ 0.00 (0%)
CNERGY 4.39 Increased By ▲ 0.05 (1.15%)
DFML 28.55 Decreased By ▼ -0.99 (-3.35%)
DGKC 82.40 Decreased By ▼ -1.15 (-1.38%)
FCCL 21.95 Decreased By ▼ -0.48 (-2.14%)
FFBL 34.15 Decreased By ▼ -0.75 (-2.15%)
FFL 10.08 Increased By ▲ 0.21 (2.13%)
GGL 10.12 Increased By ▲ 0.12 (1.2%)
HBL 113.00 Increased By ▲ 1.00 (0.89%)
HUBC 140.50 Increased By ▲ 2.81 (2.04%)
HUMNL 8.03 Increased By ▲ 1.05 (15.04%)
KEL 4.38 Decreased By ▼ -0.02 (-0.45%)
KOSM 4.50 Decreased By ▼ -0.09 (-1.96%)
MLCF 38.01 Decreased By ▼ -0.54 (-1.4%)
OGDC 134.69 Decreased By ▼ -1.91 (-1.4%)
PAEL 26.62 Increased By ▲ 1.48 (5.89%)
PIAA 25.40 Decreased By ▼ -1.11 (-4.19%)
PIBTL 6.55 Decreased By ▼ -0.10 (-1.5%)
PPL 121.95 Decreased By ▼ -3.45 (-2.75%)
PRL 27.73 Decreased By ▼ -0.48 (-1.7%)
PTC 13.80 Decreased By ▼ -0.50 (-3.5%)
SEARL 54.89 Increased By ▲ 0.29 (0.53%)
SNGP 69.70 Decreased By ▼ -1.50 (-2.11%)
SSGC 10.40 Decreased By ▼ -0.10 (-0.95%)
TELE 8.50 Decreased By ▼ -0.02 (-0.23%)
TPLP 10.95 Increased By ▲ 0.01 (0.09%)
TRG 60.90 Increased By ▲ 0.20 (0.33%)
UNITY 25.22 Decreased By ▼ -0.11 (-0.43%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
BR100 7,638 No Change 0 (0%)
BR30 24,972 No Change 0 (0%)
KSE100 72,761 No Change 0 (0%)
KSE30 23,625 No Change 0 (0%)

BEIJING: Pakistan, China will jointly build a cancer medical laboratory through cooperative partnership.

In this connection, an agreement’s signing ceremony of Pakistan-China biotechnology strategic cooperation was held here, Gwadar Pro reported on Tuesday. Under the flagship project of this cooperation, Pakistani and Chinese companies will jointly build a cancer medical laboratory. The agreement was jointly initiated and signed by Life Rehealth Technology Pakistan and Beijing Anlong Gene Medicine Technology.

Under the proposed framework, Pakistani and Chinese companies will jointly carry out exploration and research on cancer medical treatment, and Chinese companies will also share their existing medical technologies with Pakistan.

Dr Ahmed Waqas, the CEO of Life Rehealth, has been active in CPEC medical cooperation for a long-term. He said in an exclusive interview that, the incidence of cancer in Pakistan is very high, especially lung cancer, liver cancer and so on. However, due to the current medical level and sanitary conditions, patients cannot receive good treatments. Therefore, cooperation between Pakistan and China in this sector is very necessary and will bring great benefits to Pakistan.

Regarding the reasons why Pakistan chose Chinese company as cooperative partner, Waqas said, the cooperation in medical field is of great importance and requires profound friendship and trust between the two sides.

Comments

Comments are closed.